Drug:
Reaction: PRODUCT STORAGE ERROR
20250101 - 20251231
No. 401 - 500
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
401 | 25061484 |
US |
61 | 2 |
Headache, Product storage error, |
||||
TIRZEPATIDE, |
||||
402 | 25061520 |
US |
||
Product storage error, |
||||
MESALAMINE, |
||||
403 | 25061524 |
US |
2 | |
Product storage error, Product packaging issue, Abdominal distension, Condition aggravated, Drug ineffective, |
||||
MESALAMINE, |
||||
404 | 25061531 |
US |
1 | |
Injection site discharge, Injection site pain, Wrong technique in product usage process, Product storage error, |
||||
SOMATROPIN, SOMATROPIN, |
||||
405 | 25061643 |
US |
1 | |
Surgery, Blood glucose increased, Dizziness, Pyrexia, Drug ineffective, Product storage error, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
406 | 25061899 |
GB |
||
Haematochezia, Product storage error, Product dose omission in error, Product prescribing issue, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
407 | 25062239 |
US |
1 | |
Therapeutic product effect decreased, Product storage error, Poor quality product administered, Product quality issue, |
||||
PERFLUOROHEXYLOCTANE, |
||||
408 | 25062410 |
US |
||
Product storage error, |
||||
BELATACEPT, |
||||
409 | 25062508 |
US |
66 | 2 |
Weight increased, Product storage error, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
410 | 25062883 |
US |
2 | |
Product storage error, |
||||
BELIMUMAB, |
||||
411 | 25063472 |
CA |
64 | 2 |
Asthma, Blindness, Blood pressure systolic increased, Body temperature decreased, Drug intolerance, Dysphonia, Dyspnoea, Eczema eyelids, Eye pruritus, Foreign body sensation in eyes, Gait disturbance, Heart rate increased, Injection site discomfort, Injection site pain, Macular degeneration, Mass, Nasopharyngitis, Pain in extremity, Product storage error, Rash, Retinal detachment, Stress, Urticaria, Wheezing, Wound, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, |
||||
412 | 25063480 |
US |
71 | 2 |
Product storage error, Hypoacusis, |
||||
ABATACEPT, LOSARTAN, PREGABALIN, DULOXETINE HYDROCHLORIDE, DULOXETINE, APIXABAN, EZETIMIBE, BACLOFEN, MAGNESIUM, |
||||
413 | 25063591 |
US |
53 | 2 |
Therapeutic product ineffective, Product administered at inappropriate site, Product dose omission issue, Product storage error, Product adhesion issue, Product residue present, Device issue, |
||||
414 | 25063748 |
US |
||
Product storage error, No adverse event, |
||||
DORNASE ALFA, |
||||
415 | 25063749 |
US |
||
Product storage error, No adverse event, |
||||
DORNASE ALFA, |
||||
416 | 25064418 |
CA |
30 | 1 |
Accident at work, Asthma, Blood pressure increased, Bronchitis, COVID-19, Cough, Drug hypersensitivity, Illness, Inappropriate schedule of product administration, Influenza, Malaise, Musculoskeletal pain, Nasal discharge discolouration, Pharyngitis, Product storage error, Productive cough, Sinusitis, Sputum discoloured, Weight increased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ACLIDINIUM BROMIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, LORAZEPAM, FLUTICASONE FUROATE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, |
||||
417 | 25064670 |
US |
1 | 2 |
Product storage error, No adverse event, |
||||
418 | 25064673 |
US |
5 | 1 |
Product storage error, No adverse event, |
||||
419 | 25064737 |
US |
||
Product storage error, Product temperature excursion issue, |
||||
DIAZEPAM, |
||||
420 | 25064766 |
US |
||
Product temperature excursion issue, Product storage error, |
||||
DIAZEPAM, LEVETIRACETAM, |
||||
421 | 25064803 |
CA |
43 | 2 |
COVID-19, Decreased immune responsiveness, Diverticulitis, Dyspepsia, Erythema, Eye pruritus, Eye swelling, Fatigue, Feeling abnormal, Hypersensitivity, Infected cyst, Intervertebral disc protrusion, Weight decreased, Pain, Pneumonia, Pruritus, Rash, Rhinorrhoea, Skin plaque, Sneezing, Urticaria chronic, Swelling, Nasopharyngitis, Oropharyngeal pain, Urticaria, Product storage error, Product dose omission issue, Inappropriate schedule of product administration, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, |
||||
422 | 25064843 |
US |
||
Product storage error, No adverse event, |
||||
423 | 25065038 |
US |
64 | 2 |
Blood glucose increased, Product storage error, |
||||
INSULIN HUMAN, |
||||
424 | 25065109 |
US |
69 | 1 |
Blood glucose increased, Product storage error, |
||||
INSULIN LISPRO, |
||||
425 | 25065137 |
US |
||
Product storage error, |
||||
426 | 25065557 |
US |
||
Product storage error, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, |
||||
427 | 25056499 |
US |
2 | |
Wrong technique in product usage process, Product storage error, Wrong technique in device usage process, |
||||
ALBUTEROL SULFATE, |
||||
428 | 25056538 |
US |
||
Product storage error, |
||||
NIRSEVIMAB, |
||||
429 | 25056638 |
US |
43 | 1 |
Blood test abnormal, Accidental underdose, Product storage error, |
||||
INSULIN LISPRO, |
||||
430 | 25056813 |
US |
82 | 2 |
Product storage error, |
||||
INSULIN GLARGINE, |
||||
431 | 25056886 |
US |
1 | |
Product storage error, |
||||
BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, |
||||
432 | 25056928 |
GB |
||
Decreased appetite, Product storage error, |
||||
ADALIMUMAB, |
||||
433 | 25056996 |
CN |
39 | 1 |
Psoas abscess, Blood glucose increased, Device information output issue, Product storage error, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
434 | 25057042 |
CA |
63 | 1 |
Device malfunction, Device issue, Injection site swelling, Injection site pruritus, Device delivery system issue, Incorrect dose administered by device, Product storage error, |
||||
SEMAGLUTIDE, |
||||
435 | 25057102 |
US |
||
Product storage error, |
||||
TENOFOVIR DISOPROXIL FUMARATE, TENOFOVIR DISOPROXIL FUMARATE TABLETS, |
||||
436 | 25057113 |
US |
||
Unevaluable event, Product storage error, Intercepted product administration error, |
||||
INTERFERON GAMMA-1B, |
||||
437 | 25057413 |
US |
13 | 2 |
Infection, Product storage error, Glycosylated haemoglobin increased, Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, |
||||
438 | 25057416 |
US |
||
Product storage error, |
||||
439 | 25057626 |
US |
25 | 2 |
Product dose omission in error, Product storage error, |
||||
ABATACEPT, |
||||
440 | 25058644 |
US |
||
Product storage error, |
||||
CANAKINUMAB, |
||||
441 | 25058749 |
US |
||
Product storage error, |
||||
DABRAFENIB, |
||||
442 | 25058806 |
US |
57 | 1 |
Product storage error, Product dose omission issue, |
||||
GUSELKUMAB, GUSELKUMAB, |
||||
443 | 25059446 |
US |
2 | |
Rehabilitation therapy, Product storage error, |
||||
LINACLOTIDE, |
||||
444 | 25059729 |
US |
||
Product storage error, |
||||
NILOTINIB, |
||||
445 | 25059898 |
US |
63 | 2 |
Product storage error, Product packaging quantity issue, Product container seal issue, |
||||
LATANOPROST, LATANOPROST, LATANOPROST, |
||||
446 | 25059927 |
US |
||
Product storage error, No adverse event, |
||||
447 | 25060089 |
US |
2 | |
Product storage error, |
||||
SARILUMAB, SARILUMAB, |
||||
448 | 25060118 |
US |
65 | 1 |
Product storage error, |
||||
INSULIN GLARGINE, |
||||
449 | 25060124 |
VE |
68 | 2 |
Death, Chills, Tremor, Product storage error, Suspected counterfeit product, |
||||
PEMBROLIZUMAB, |
||||
450 | 25060452 |
US |
||
Product storage error, |
||||
451 | 25061061 |
US |
||
Product dose omission issue, Product temperature excursion issue, Product label issue, Product storage error, |
||||
GUSELKUMAB, |
||||
452 | 25061071 |
US |
42 | 1 |
Product storage error, |
||||
USTEKINUMAB, |
||||
453 | 25061253 |
US |
2 | |
Product storage error, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, |
||||
454 | 25055760 |
US |
2 | |
Product storage error, |
||||
INSULIN GLARGINE, |
||||
455 | 25055916 |
US |
||
Product storage error, No adverse event, |
||||
456 | 25055952 |
US |
45 | 2 |
Product storage error, Product dose omission issue, |
||||
GUSELKUMAB, |
||||
457 | 25056002 |
US |
1 | |
Product storage error, |
||||
ALBUTEROL SULFATE, |
||||
458 | 25056006 |
US |
28 | 2 |
Blood glucose increased, Product storage error, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
459 | 25056020 |
US |
||
Product storage error, |
||||
SECUKINUMAB, |
||||
460 | 25056118 |
US |
46 | |
Extra dose administered, Product storage error, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
461 | 25056131 |
US |
67 | 1 |
Illness, Sinus disorder, Product storage error, Intercepted product administration error, |
||||
EVOLOCUMAB, |
||||
462 | 25054578 |
US |
2 | |
Product storage error, |
||||
INSULIN GLARGINE, |
||||
463 | 25054622 |
US |
72 | 2 |
Product storage error, |
||||
INSULIN GLARGINE, SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, GLIMEPIRIDE, |
||||
464 | 25054725 |
US |
1 | |
Wrong technique in product usage process, Product storage error, |
||||
ALBUTEROL SULFATE, |
||||
465 | 25054884 |
US |
||
Product storage error, |
||||
BELATACEPT, |
||||
466 | 25054969 |
US |
||
Product storage error, |
||||
UPADACITINIB, |
||||
467 | 25055086 |
US |
67 | 1 |
Blood glucose increased, Dizziness, Product storage error, |
||||
ADALIMUMAB, |
||||
468 | 25055095 |
US |
||
Product storage error, |
||||
DUPILUMAB, |
||||
469 | 25055264 |
US |
2 | |
Product dose omission issue, Product storage error, |
||||
GUSELKUMAB, |
||||
470 | 25055462 |
US |
1 | |
Product storage error, |
||||
GUSELKUMAB, |
||||
471 | 25055485 |
US |
61 | 2 |
Product storage error, |
||||
INSULIN GLARGINE, |
||||
472 | 25055607 |
US |
2 | |
Product storage error, Product dose omission issue, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
473 | 25048289 |
US |
2 | |
Pruritus, Paraesthesia, Nerve injury, Inflammation, Product storage error, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
474 | 25048333 |
US |
66 | 2 |
Fatigue, Product storage error, Increased appetite, Abdominal pain upper, |
||||
TIRZEPATIDE, |
||||
475 | 25048384 |
US |
2 | |
No adverse event, Product storage error, |
||||
IDURSULFASE, |
||||
476 | 25048473 |
US |
||
Intercepted product storage error, Product storage error, |
||||
477 | 25048474 |
US |
||
Product storage error, Intercepted product storage error, |
||||
478 | 25048534 |
US |
||
Product storage error, Injection site rash, |
||||
TIRZEPATIDE, |
||||
479 | 25048701 |
US |
47 | 1 |
Product storage error, Incorrect dose administered, Injection site haemorrhage, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
480 | 25048801 |
US |
1 | |
Product storage error, Wrong technique in product usage process, Product complaint, |
||||
FLUTICASONE PROPIONATE, |
||||
481 | 25049060 |
US |
2 | |
Injection site pain, Product storage error, Circumstance or information capable of leading to medication error, |
||||
EVOLOCUMAB, |
||||
482 | 25049360 |
AU |
40 | 2 |
Rectal haemorrhage, Product temperature excursion issue, Inappropriate schedule of product administration, Product storage error, Product dispensing error, Spleen disorder, Haemangioma of liver, Underdose, |
||||
VELAGLUCERASE ALFA, VELAGLUCERASE ALFA, VELAGLUCERASE ALFA, VELAGLUCERASE ALFA, |
||||
483 | 25049517 |
US |
||
Gastrooesophageal reflux disease, Product use issue, Product storage error, |
||||
ESOMEPRAZOLE MAGNESIUM, |
||||
484 | 25050246 |
US |
1 | |
Product storage error, |
||||
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE, |
||||
485 | 25050417 |
US |
||
Product storage error, |
||||
LUSPATERCEPT, LUSPATERCEPT, |
||||
486 | 25051074 |
US |
||
Product storage error, |
||||
RILPIVIRINE HYDROCHLORIDE, |
||||
487 | 25051152 |
US |
37 | 2 |
Illness, Product storage error, |
||||
ADALIMUMAB-BWWD, ADALIMUMAB-BWWD, |
||||
488 | 25051272 |
US |
12 | 1 |
Product storage error, No adverse event, |
||||
489 | 25051382 |
US |
2 | 2 |
Product storage error, No adverse event, |
||||
CEPHALEXIN, |
||||
490 | 25051584 |
US |
13 | 1 |
Device leakage, Product storage error, Product administration error, |
||||
SOMATROPIN, SOMATROPIN, |
||||
491 | 25051858 |
US |
||
Product storage error, No adverse event, |
||||
492 | 25052040 |
US |
24 | 1 |
Arthralgia, Drug ineffective, Product storage error, |
||||
ADALIMUMAB-BWWD, |
||||
493 | 25052103 |
US |
||
Product storage error, |
||||
OFATUMUMAB, |
||||
494 | 25052531 |
BR |
1 | |
Head injury, Fall, Product storage error, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, |
||||
495 | 25052765 |
US |
77 | 2 |
Cataract, Visual impairment, Product storage error, Intentional product misuse, |
||||
INSULIN LISPRO, |
||||
496 | 25052767 |
US |
56 | 2 |
Blood glucose increased, Device issue, Product dispensing error, Product storage error, |
||||
INSULIN GLARGINE, |
||||
497 | 25053064 |
US |
53 | 2 |
Product storage error, |
||||
INSULIN GLARGINE, |
||||
498 | 25053086 |
US |
76 | 1 |
Product storage error, |
||||
INSULIN GLARGINE, |
||||
499 | 25053110 |
US |
62 | 2 |
Product storage error, |
||||
INSULIN GLARGINE, |
||||
500 | 25053173 |
US |
48 | 2 |
Product dispensing error, Product storage error, |
||||
INSULIN GLARGINE, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28